Adipotide CAS:859216-15-2

FTPP (Adipotide) is a peptidomimetic (a small protein-like chain designed to mimic a peptide), transformed into an experimental proapoptotic drug used for cellular death. Its purpose is to contribute in the weight loss. This substance has shown favorable results in tests and its main feature is its property of rapid loss weight.

Adipotide is designed to target specific blood vessels, supplying adipose tissue with blood. This process causes a shrinking effect on vessels, which forces the fat cells to feed on those vessels. All this mechanism gives origin to an apoptosis, which is a process of programmed cell death of multicellular organisms. There are two receptors where Adipotide binds: ANXA2 and prohibitin; these are found in blood vessels and accomplish the function of supplying white adipose tissue.

Adipotide help people in reducing their weight in a few months. When Adipotide cuts off the blood supply to fat cells, this process causes the loss of a certain amount of body weight and at the same time an additional amount of belly fat mass loss.

It contains potentiating effects on insulin sensitivity, improving it drastically. It is reflected in a more efficient use of insulin on the body, which has a positive effect on reducing elevated blood glucose levels. This process maintains health and allows the use of the energy from the chemical nutrients that the body receives.

The optimal dose of 43 mg/kg have been used on monkeys which resulted in no side effects. This dose cannot be equated to humans since this substance is used only for research purposes.